Abceutics

Buffalo, United States Founded: 2020 • Age: 6 yrs Acquired By Merck
Antibody-drug conjugates for cancer treatment are enhanced by Abceutics.

About Abceutics

Abceutics is a Healthcare company based in Buffalo (United States) founded in 2020 by Larry C Wienkers, and was acquired by Merck in April 2024. Antibody-drug conjugates for cancer treatment are enhanced by Abceutics. Its focus areas include Traditional Pharmaceuticals.

Company details

Abceutics Inc. was founded in 2020 and is based in Buffalo, United States. Operations are centered on biotechnology as a preclinical-stage biopharmaceutical company. Antibody-drug conjugates are enhanced for cancer treatment, with development directed toward new autoimmune drugs. Patient outcomes are targeted for improvement through these efforts in the sector.

  • Headquarters Buffalo, United States
  • Founders Larry C Wienkers
  • Stage Acquired
  • Sectors
    Healthcare
  • Website abceuticsinc.com
  • Acquired by Merck (Apr 2024)
Key Metrics

Investors in Abceutics

Abceutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merck.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical products are manufactured and marketed worldwide.
1891merck.comKenilworth, United Kingdom
Premium access

Investor details for Abceutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Abceutics

1 people are tracked at Abceutics (1 in leadership).

NameRoleGroup
Larry C Wienkers
Co-FounderLeadership
Premium access

Complete people profiles for Abceutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Abceutics

2 dated milestones of Abceutics across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Abceutics is founded.
  2. Exit Acquired by Merck.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Abceutics (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Abceutics

Abceutics was founded in 2020.

Abceutics is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.

Abceutics Inc. was founded in 2020 and is based in Buffalo, United States. Operations are centered on biotechnology as a preclinical-stage biopharmaceutical company. Antibody-drug conjugates are enhanced for cancer treatment, with development directed toward new autoimmune drugs. Patient outcomes are targeted for improvement through these efforts in the sector.

Abceutics has 1 investor. Key investors include Merck.

Yes. Abceutics was acquired by Merck in April 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available